Results 61 to 70 of about 18,946 (139)

Artificial intelligence for the diagnosis of heart failure

open access: yesnpj Digital Medicine, 2020
The diagnosis of heart failure can be difficult, even for heart failure specialists. Artificial Intelligence-Clinical Decision Support System (AI-CDSS) has the potential to assist physicians in heart failure diagnosis.
Dong-Ju Choi   +3 more
doaj   +1 more source

Angiotensin receptor neprilysin inhibition versus individualized RAAS blockade: design and rationale of the PARALLAX trial

open access: yesESC Heart Failure, 2020
Aims Although the effect of the angiotensin receptor blocker neprilysin inhibitor (ARNI) sacubitril/valsartan on heart failure (HF) hospitalizations and cardiovascular death has been evaluated, its effects on functional capacity in patients with HF and ...
Rolf Wachter   +9 more
doaj   +1 more source

Heart failure with mid‐range ejection fraction: causes and consequences [PDF]

open access: yesEuropean Journal of Heart Failure, 2018
Tromp, Jasper   +2 more
openaire   +3 more sources

Predictors of cardiac function in acute heart failure patients with mid‐range ejection fraction: AURORA study

open access: yesESC Heart Failure, 2019
Aim The factors correlated with prognosis in heart failure with mid‐range ejection fraction (HFmrEF) is unclear, especially for acute heart failure (AHF) with HFmrEF.
Kyosuke Yanagawa   +14 more
doaj   +1 more source

Trends in cause‐specific readmissions in heart failure with preserved vs. reduced and mid‐range ejection fraction

open access: yesESC Heart Failure, 2020
Aims The aim of this study was to investigate whether the readmission of heart failure (HF) patients has decreased over time and how it differs among HF with preserved ejection fraction (EF) (HFpEF) vs.
Xiaotong Cui   +5 more
doaj   +1 more source

Effect of sacubitril valsartan on heart failure with mid-range or preserved ejection fraction in patients on maintenance hemodialysis: real-world experience in a single-center, prospective study

open access: yesBMC Cardiovascular Disorders
Background This study aimed to evaluate the effect of sacubitril valsartan (SV) on heart failure (HF) hospitalization and cardiovascular mortality in patients on hemodialysis with HF with preserved ejection fraction (EF; HFpEF).
Xiao-mei Huang   +9 more
doaj   +1 more source

β-blocker and 1-year outcomes among patients hospitalized for heart failure with mid-range ejection fraction. [PDF]

open access: yesEur Heart J Cardiovasc Pharmacother, 2022
Wang B   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy